In a historic milestone for global public health, the World Health Organization (WHO) has officially validated Tunisia as having successfully eliminated trachoma as a public health problem. This achievement represents the culmination of decades of rigorous, sustained, and multi-faceted national effort, marking a significant victory against the world’s leading infectious cause of blindness.
Once a pervasive health burden that crippled the vision of thousands, particularly in the nation’s southern regions, trachoma has now been relegated to history in Tunisia. The validation serves as a powerful testament to the efficacy of long-term political commitment, the strength of primary healthcare systems, and the transformative power of community-led hygiene and sanitation initiatives.
The Magnitude of the Achievement
Trachoma, a disease caused by the bacterium Chlamydia trachomatis, has historically been synonymous with poverty and limited access to water and sanitation. During the early to mid-20th century, the disease was endemic across Tunisia, affecting at least half of the population. Its progression—often starting as a recurring infection and leading to scarring of the eyelids that causes eyelashes to turn inward—frequently resulted in irreversible blindness.
By achieving this validation, Tunisia has demonstrated that even deeply entrenched neglected tropical diseases (NTDs) can be overcome through science-based programming and consistent public policy. Tunisia now stands as the 31st country globally to be validated by the WHO for the elimination of trachoma, and it is the first time the country has officially eliminated an NTD, setting a benchmark for the entire Eastern Mediterranean region.
A Chronology of Success: The Path to Elimination
The journey to this moment was not sudden; it was the result of a systematic, decades-long campaign led by the Tunisian Ministry of Health in close partnership with the WHO.
The Mid-20th Century: The Burden
In the decades following the mid-1900s, trachoma was a major public health crisis in Tunisia. The disease disproportionately affected the most vulnerable populations, thriving in areas where water access was scarce and sanitation infrastructure was underdeveloped. The social and economic toll was immense, as entire communities grappled with the loss of productivity and the high cost of managing advanced cases of blindness.
The Adoption of the SAFE Strategy
Central to Tunisia’s success was the adoption and meticulous scaling of the WHO-recommended SAFE strategy. This comprehensive framework provided the roadmap for the country’s intervention:
- S (Surgery): Providing corrective surgical procedures for those suffering from trachomatous trichiasis (the stage where eyelashes turn inward).
- A (Antibiotics): Distributing mass treatments to clear active infections within the population.
- F (Facial Cleanliness): Implementing nationwide education campaigns to reduce the transmission of the bacteria.
- E (Environmental Improvement): A massive, long-term focus on improving access to clean water and sanitation, which effectively disrupted the cycle of transmission.
Integrated Health Systems
Beyond the SAFE strategy, Tunisia took the decisive step of integrating eye care into its primary healthcare network and school health programs. By embedding screening and treatment into the daily operations of the national health system, the country ensured that no community—no matter how remote—was left behind.
Supporting Data and Technical Benchmarks
The WHO’s validation process is rigorous and evidence-based. To be declared free of trachoma as a public health problem, a country must meet specific, stringent criteria:
- Trachomatous Trichiasis (TT): A prevalence of "unknown to the health system" cases of less than 0.2% in individuals aged 15 and older.
- Trachomatous Inflammation-Follicular (TF): A prevalence of less than 5% in children aged 1–9 years in every formerly endemic district.
- Surveillance: The proven existence of a robust, ongoing system to identify and manage any new, incident cases of TT.
Tunisia’s adherence to these metrics, combined with its success in water and sanitation coverage, allowed it to push disease prevalence down to near-zero levels. A sophisticated post-validation surveillance system is now fully operational, ensuring that health professionals remain trained and vigilant, capable of detecting and responding to any potential resurgence at the earliest possible stage.
Official Perspectives: A Unified Vision
The validation of this achievement drew praise from the highest levels of global health governance.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, remarked: "I congratulate Tunisia on this historic public health achievement. Eliminating trachoma shows what long-term political commitment, strong primary health care and teamwork can do. Tunisia has proven that even the world’s leading infectious cause of blindness can be overcome."
Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, highlighted the consistency of the effort: "This is a major achievement that reflects sustained and consistent national commitment over many years and shows what is possible when a country remains focused on addressing preventable causes of blindness."
From the perspective of the Tunisian government, the victory is seen as a reflection of national values. Dr. Mustapha Ferjani, Minister of Health of Tunisia, stated: "Validation marks a historic achievement for Tunisia and reflects our country’s long-standing commitment to public health, prevention and equity. This milestone is the result of decades of coordinated national efforts, with the dedication of generations of health-care professionals, local communities who worked tirelessly to expand access to care, strengthen prevention and improve eye health across the country."
Dr. Ahmed Zouiten, Acting WHO Representative in Tunisia, noted the importance of the partnership: "This milestone stands as a strong demonstration of how science, evidence-based programming and coordinated technical support can overcome neglected tropical diseases every time and everywhere."
Global Implications and the Future
Tunisia’s success is a vital component of the broader global effort to address neglected tropical diseases—a key objective within the United Nations’ Sustainable Development Goals.
A Regional and Global Trend
Tunisia’s achievement makes it the 14th country in the WHO Eastern Mediterranean Region to eliminate at least one NTD. This progress is part of a larger global momentum supported by the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020), an initiative that has networked governments, NGOs, and academic institutions since 1996.
The Road Ahead: 2030 and Beyond
While the 2020 target date has passed, the global community has set its sights on 2030 as the new deadline for the worldwide elimination of trachoma. The Road Map for Neglected Tropical Diseases 2021–2030 provides the framework for these efforts. Tunisia’s role as a successful case study is invaluable; it provides a blueprint for other nations still struggling with the burden of trachoma and other NTDs.
Lessons Learned
The primary lesson from the Tunisian model is that health outcomes are inextricable from social development. By improving water and sanitation infrastructure, Tunisia did not just treat a disease—it improved the fundamental quality of life for its citizens. Furthermore, the integration of eye health into the existing primary care framework prevented the fragmentation of services, ensuring that the health system remained resilient and comprehensive.
Conclusion
The validation of Tunisia’s trachoma elimination is more than a line item in a WHO report; it is a profound human success story. It represents the liberation of countless individuals from the threat of preventable blindness and the empowerment of a nation that refused to let an infectious disease define its future. As Tunisia moves forward with its robust surveillance system to protect these gains for future generations, the rest of the world looks on, finding in this achievement the hope and evidence that a world free of neglected tropical diseases is not only possible but within our reach.
About the Author
